MedPath

Metal Versus Plastic Stent in Malignant Hilar Biliary Obstruction

Not Applicable
Conditions
Malignant Hepatobiliary Neoplasm
Registration Number
NCT03857958
Lead Sponsor
Seoul National University Hospital
Brief Summary

The purpose of this study was to compare the difference in the stent patency duration between side-by-side fully covered self-expanding metal stents (SEMS) and side-by-side plastic stents in patients with malignant hilar biliary obstruction.

Detailed Description

In the case of distal common bile duct obstruction, the SEMS was reported to be clinically superior to the plastic stent in previous studies. However, there are few studies comparing the two methods in patients with malignant hilar biliary obstruction. In contrast to the distal common bile duct obstruction, the advantage of plastic stents over SEMSs exists, and plastic stents are used commonly in real clinical practice.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
54
Inclusion Criteria
  • Unresectable malignant hilar biliary stricture requiring biliary drainage through endoscopic procedure
Exclusion Criteria
  • If endoscopy is not possible based on the judgement of the researcher
  • Life expectancy less than 6 months
  • Acute cholecystitis
  • Previous history of percutaneous transhepatic biliary drainage
  • Previous history of metal stent placement for malignant biliary stricture

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Duration of stent patency9 months after randomization.

The period from the insertion of the stent to the point at which stent revision is required.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

Seoul National University Hospital
🇰🇷Seoul, Korea, Republic of
Min su You, MD
Contact
82-2-2072-2228
bass105@hanmail.net
Woo Hyun Paik, MD, PhD
Contact
82-2-2072-2228
whpaik@snuh.org

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.